E
BioLineRx Ltd. BLRX
$3.61 -$0.24-6.23% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -176.85% 260.87% 45.26% -1,302.89% 169.54%
Total Depreciation and Amortization 6.67% -90.73% 111.79% 76.47% -46.93%
Total Amortization of Deferred Charges -100.00% -5.39% -- -- --
Total Other Non-Cash Items 121.27% -7.14% -434.71% 75.40% -61.78%
Change in Net Operating Assets 464.52% -25.12% 88.06% 52.33% 33.11%
Cash from Operations 93.17% 69.91% 12.37% 13.28% 19.70%
Capital Expenditure -- -- -- 100.00% 15.63%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 54.57% -173.33% 9.59% 218.07% -151.55%
Cash from Investing 54.70% -173.29% 9.65% 217.70% -151.81%
Total Debt Issued -- -- -- -100.00% --
Total Debt Repaid -0.64% 89.70% -1,065.99% -14.19% -1.68%
Issuance of Common Stock -73.29% -2.70% -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -83.05% 952.12% 8.95% -105.10% 2,771.03%
Foreign Exchange rate Adjustments 626.83% -150.62% 100.00% 129.78% -633.33%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -31.93% -187.50% 303.30% -121.66% 109.39%